Spread the loveWhen you hear the name Eric Lefkofsky, your mind probably jumps straight to Groupon. And for good reason – he ...

Medical Radiology Manipulator Ludovic Foy prepares a woman before she has a lung scan for the Acapulco experimentation in Ajaccio on December 16, 2021 on the French Mediterranean island of Corsica. - ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AI data company Tempus AI announced it will acquire cancer genomics company Personalis in a transaction valued at approximately $1.5 billion. The acquisition will integrate Personalis' molecular ...

July 20 (Reuters) - Tempus AI (TEM.O), opens new tab said on Monday it would buy Personalis (PSNL.O), opens new tab in a deal valued at about $1.5 billion, ‌adding a cancer test to the AI-enabled ...

July 20 (Reuters) - Tempus AI said on Monday it would buy Personalis in a deal valued at about $1.5 billion, adding a cancer test to the AI-enabled precision medicine firm's oncology portfolio.

Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology. Tempus, which is putting a total enterprise value of $1.5 billion on ...

Tempus AI offers employees opportunities to grow through exposure to rapidly evolving technologies, cross-functional collaboration, expanding business areas, and the chance to build expertise at the ...

Tempus AI's culture is centered around mission-driven innovation, collaboration across disciplines, continuous learning, and a shared commitment to improving patient outcomes through data and ...

Inaugural program provides unprecedented access to Tempus’ library of de-identified multimodal data and models, scalable compute infrastructure and direct funding to catalyze clinical and technical ...

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Merck, known as MSD outside of the United States and Canada ...